Breast Cancer Coverage from Every Angle

William J. Gradishar, MD, on Atezolizumab and Nab-paclitaxel in Triple-Negative Breast Cancer

Posted: Monday, June 10, 2019

Based on the IMpassion130 trial, which patients with triple-negative breast cancer would you most likely consider for treatment with the combination of atezolizumab and nab-paclitaxel?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.